Vnitr Lek 2016, 62(Suppl 2):18-22

Extrahepatic manifestations of HCV infection

Petr Husa
Klinika infekčních chorob LF MU a FN Brno, pracoviště Bohunice

Extrahepatic manifestations of hepatitis C virus infection (HCV) are very common. The most common of these is mixed cryoglobulinaemia. Anti-HCV antibodies and viral ribonucleic acid, HCV RNA, can be found in the cryoprecipitates, together with the rheumatoid factor. Cryoglobulins consist of a complex of immunoglobulins that in vitro precipitate upon the cooling bellow the human body temperature. Vasculitis is caused by the deposition of such immune complexes in the small blood vessels. A link with the HCV infection is considered to be established with membranoproliferative glomerulonephritis, leukocytoclastic vasculitis, lymphoproliferative disorders (in particular B cell lymphoma), Sjögren and sicca syndrome, lichen planus, porfyria cutanea tarda and diabetes mellitus. Very probable is the relationship of chronic HCV infection and thyroid disease, arthralgias, otherwise unexplained fatigue and autoimmune hepatitis.

Keywords: direct acting antivirals; extrahepatic manifestations; chronic hepatitis C; mixed cryoglobulinaemia

Received: September 2, 2016; Published: April 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P. Extrahepatic manifestations of HCV infection. Vnitr Lek. 2016;62(Supplementum 2):18-22.
Download citation

References

  1. Tillmann HL, McHutchison JG. Hepatitis C. In: Boyer TD, Manns MP, Sanyal A. Zakim and Boyer's Hepatology: A Textbook of Liver Disease. 6th ed. Elsevier Saunders: Philadelphia 2011: 574-576. ISBN 978-1437708813.
  2. [European Association for the Study of Liver]. EASL recommendations on treatment of hepatitis C 2014. J Hepatol 2014; 61(2): 373-395. Go to original source... Go to PubMed...
  3. Pascual M, Perrin L, Giostra E et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162(2): 569-570. Go to original source... Go to PubMed...
  4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327(21): 1490-1495. Go to original source... Go to PubMed...
  5. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117(7): 573-577. Go to original source... Go to PubMed...
  6. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19(4): 841-848. Go to original source... Go to PubMed...
  7. American Association for the study of Liver Diseases. AASLD recommendation for testing, managing, and treating hepatitis C. Dostupné z WWW: <www.hcvguidelines.org>. [3.8.2016].
  8. Schott P, Hartmann H, Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanism of cryoprecipitation and options of treatment. Histol Histopathol 2001; 16(4): 1275-1285. Go to PubMed...
  9. Cicardi M, Cesana B, Del Ninno E et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepatol 2000; 7(2): 138-143. Go to original source... Go to PubMed...
  10. Hoofnagle JH, Heller T. Hepatitis C. In: Zakim D, Boyer TD. Hepatology. A Textbook of Liver Disease. 4th ed. Saunders: Philadelphia 2002: 1017-1062. ISBN 978-0721690513.
  11. Fraňková S, Urbánek P, Šperl J et al. Diagnostický a terapeutický postup chronické infekce virem hepatitidy C u pacientů s chronickým onemocněním ledvin. Aktuality v nefrologii 2016; 22(2): 63-65.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.